A

Alcobra (NASDAQ: ADHD)

2 employees

Alcobra Pharmaceuticals Inc. which is developing a treatment for attention deficit hyperactivity disorder (ADHD).

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Fragile X Syndrome
Cognitive dysfunctions
Attention Deficit Disorder (ADD)
Attention Deficit Hyperactivity Disorder (ADHD)
Cognitive dysregulation
Cognitive disorders
Adult ADHD
Biopharmaceuticals
Pharmaceuticals
Cognitive impairment

Date founded

2008

Funding rounds raised

Total raised

$8.2M

from 1 investors over 1 rounds

A

Alcobra (NASDAQ: ADHD) raised $8.2M on March 1, 2014

Investors: Cybele Holdings

FAQ